Federal investment to increase Canada’s capacity to develop and manufacture critical medicines
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and integrated research, development, and manufacturing initiative that will strengthen Alberta’s biomedical sector and increase the domestic production of critical medicines.
This project aligned with Canada’s Biomanufacturing and Life Sciences Strategy.
Tags:
Source: Government of Canada
Credit:
